{"id":1000515,"date":"2026-09-03T19:27:00","date_gmt":"2026-09-03T23:27:00","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\/"},"modified":"2026-09-03T19:27:00","modified_gmt":"2026-09-03T23:27:00","slug":"iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\/","title":{"rendered":"IQVIA&#8217;s Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster"},"content":{"rendered":"<p>        <!--.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>IQVIA&#8217;s Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster<\/b><\/p>\n<p>RESEARCH TRIANGLE PARK, N.C.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nIQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced IQVIA Predictive Clinical Development, an AI-powered approach designed to help life sciences sponsors reduce avoidable delays and bring new therapies to patients up to two years faster.<\/p>\n<p>\nTraditional approaches in clinical development no longer keep pace with increasing trial complexity. IQVIA Predictive Clinical Development is built to eliminate them, accelerating every stage of the development lifecycle with measurable results:<\/p>\n<ul class=\"bwlistdisc\">\n<li><b>33% faster study startup<\/b><\/li>\n<li><b>1.7 times more patients recruited from our AI prioritized and Prime &amp; Partner sites with 42% higher enrollment rates<\/b><\/li>\n<li><b>50% faster data cleaning<\/b><\/li>\n<li><b>45%+ reduced time between trial phases<\/b><\/li>\n<\/ul>\n<p>\nIQVIA Predictive Clinical Development pairs IQVIA&#8217;s proprietary data, deep regulatory expertise and best-in-class Healthcare-grade AI<sup>\u00ae<\/sup> with premier technologies from Anthropic, Amazon Web Services (AWS), Databricks, Microsoft, NVIDIA, Palantir and Snowflake orchestrated to drive agentic workflows.<\/p>\n<p>\n&#8220;At a time when every moment matters for patients waiting on new therapies, IQVIA Predictive Clinical Development represents a fundamental shift,&#8221; said Richard Staub, president of Research and Development Solutions at IQVIA. &#8220;We&#8217;re helping customers make development faster, more predictable and of a higher quality \u2014 compressing timelines, accelerating decisions and speeding medicines to market.&#8221;<\/p>\n<p>\nIQVIA Predictive Clinical Development is enabled by IQVIA&#8217;s clinical AI capabilities:<\/p>\n<ul class=\"bwlistdisc\">\n<li><b>Clinical Design &amp; Planning Suite <\/b>generates predictive insights to inform site selection, prioritizes sites including its Prime and Partner network and operationalizes the recruitment strategy to speed enrollment.\n<\/li>\n<li><b>Push Button Start-Up<\/b> is an integrated and streamlined delivery model that applies standardization, automation and AI-enabled processes to accelerate the time to starting patient enrollment.\n<\/li>\n<li><b>Real-time Data Cleaning <\/b>enables faster, more reliable, higher quality data to make confident decisions during and after a study. It brings clinical data together across multiple sources, drives greater efficiency and enables more rapid database locks.\n<\/li>\n<\/ul>\n<p>\nIQVIA is uniquely positioned to change the trajectory of clinical development ultimately closing the gap between scientific discovery to patient care. As IQVIA extends its leadership in AI, new components will continue to expand Predictive Clinical Development across the entire development lifecycle, helping customers move faster with confidence.<\/p>\n<p><b>To learn more about IQVIA Predictive Clinical Development, visit: <\/b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.iqvia.com%2Fsolutions%2Fresearch-and-development&amp;esheet=54598072&amp;newsitemid=20260902280330&amp;lan=en-US&amp;anchor=Clinical+Research+%26amp%3B+Development+Solutions+%7C+IQVIA&amp;index=1&amp;md5=fa8eb055591cd645003f49d1bf24c037\"><b>Clinical Research &amp; Development Solutions | IQVIA<\/b><\/a>. <b>To learn more about IQVIA AI agents, visit: <\/b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.iqvia.com%2Fsolutions%2Finnovative-models%2Fartificial-intelligence-and-machine-learning%2Fagentic-ai%23our-difference&amp;esheet=54598072&amp;newsitemid=20260902280330&amp;lan=en-US&amp;anchor=Agentic+AI+%7C+Life+Sciences+%7C+IQVIA&amp;index=2&amp;md5=0293f63e73b4404133053067e384f8c2\"><b>Agentic AI | Life Sciences | IQVIA<\/b><\/a><\/p>\n<p><b>About IQVIA<\/b><\/p>\n<p>\nIQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA\u2019s portfolio of solutions are powered by IQVIA Connected Intelligence\u2122 to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI<sup>\u00ae<\/sup>, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 94,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.<\/p>\n<p>\nIQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA\u2019s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iqvia.com&amp;esheet=54598072&amp;newsitemid=20260902280330&amp;lan=en-US&amp;anchor=www.iqvia.com&amp;index=3&amp;md5=375809c9396d3db3bd90916597784d5e\">www.iqvia.com<\/a>.<\/p>\n<p>\nIQVIAFIN<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260902280330r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260902280330\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260902280330\/en\/<\/a><\/span><\/p>\n<p>\nKerri Joseph, IQVIA Investor Relations (<a rel=\"nofollow\" href=\"mailto:kerri.joseph@iqvia.com\">kerri.joseph@iqvia.com<\/a>)<br \/>\n<br \/>+1.973.541.3558<\/p>\n<p>\nAlissa Maupin, IQVIA Media Relations (<a rel=\"nofollow\" href=\"mailto:alissa.maupin1@iqvia.com\">alissa.maupin1@iqvia.com<\/a>)<br \/>\n<br \/>+1.919.923.6785<\/p>\n<p><b>KEYWORDS:<\/b> North Carolina United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health Technology Health Technology Software General Health Artificial Intelligence Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260902280330\/en\/2888483\/3\/IQVIA_Logo-RGB.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>IQVIA&#8217;s Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster RESEARCH TRIANGLE PARK, N.C.&#8211;(BUSINESS WIRE)&#8211; IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced IQVIA Predictive Clinical Development, an AI-powered approach designed to help life sciences sponsors reduce avoidable delays and bring new therapies to patients up to two years faster. Traditional approaches in clinical development no longer keep pace with increasing trial complexity. IQVIA Predictive Clinical Development is built to eliminate them, accelerating every stage of the development lifecycle with measurable results: 33% faster study startup 1.7 times more patients recruited from our AI prioritized and Prime &amp; Partner sites with 42% higher enrollment rates 50% &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;IQVIA&#8217;s Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1000515","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IQVIA&#039;s Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IQVIA&#039;s Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"IQVIA&#8217;s Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster RESEARCH TRIANGLE PARK, N.C.&#8211;(BUSINESS WIRE)&#8211; IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced IQVIA Predictive Clinical Development, an AI-powered approach designed to help life sciences sponsors reduce avoidable delays and bring new therapies to patients up to two years faster. Traditional approaches in clinical development no longer keep pace with increasing trial complexity. IQVIA Predictive Clinical Development is built to eliminate them, accelerating every stage of the development lifecycle with measurable results: 33% faster study startup 1.7 times more patients recruited from our AI prioritized and Prime &amp; Partner sites with 42% higher enrollment rates 50% &hellip; Continue reading &quot;IQVIA&#8217;s Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-03T23:27:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260902280330r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IQVIA&#8217;s Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster\",\"datePublished\":\"2026-09-03T23:27:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\\\/\"},\"wordCount\":706,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260902280330r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\\\/\",\"name\":\"IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260902280330r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-09-03T23:27:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260902280330r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260902280330r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IQVIA&#8217;s Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\/","og_locale":"en_US","og_type":"article","og_title":"IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster - Market Newsdesk","og_description":"IQVIA&#8217;s Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster RESEARCH TRIANGLE PARK, N.C.&#8211;(BUSINESS WIRE)&#8211; IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced IQVIA Predictive Clinical Development, an AI-powered approach designed to help life sciences sponsors reduce avoidable delays and bring new therapies to patients up to two years faster. Traditional approaches in clinical development no longer keep pace with increasing trial complexity. IQVIA Predictive Clinical Development is built to eliminate them, accelerating every stage of the development lifecycle with measurable results: 33% faster study startup 1.7 times more patients recruited from our AI prioritized and Prime &amp; Partner sites with 42% higher enrollment rates 50% &hellip; Continue reading \"IQVIA&#8217;s Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-03T23:27:00+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260902280330r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IQVIA&#8217;s Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster","datePublished":"2026-09-03T23:27:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\/"},"wordCount":706,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260902280330r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\/","name":"IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260902280330r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-09-03T23:27:00+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260902280330r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260902280330r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iqvias-predictive-clinical-development-provides-sponsors-with-significant-efficiencies-to-get-treatments-to-market-faster\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IQVIA&#8217;s Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1000515","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1000515"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1000515\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1000515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1000515"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1000515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}